During the past decade, St. Lukes Roosevelt Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 40 clinical trials were completed, i.e. on average, 173.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Lukes Roosevelt Hospital" #1 sponsor was "St. Luke's-Roosevelt Hospital Center" with 20 trials, followed by "Gilead Sciences" with 5 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 5 trials sponsored, "Radiation Therapy Oncology Group" with 5 trials sponsored and "Alliance for Clinical Trials in Oncology" with 5 trials sponsored. Other sponsors include 92 different institutions and companies that sponsored additional 81 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Lukes Roosevelt Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "St. Luke's-Roosevelt Hospital Center" with 6 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "St. Lukes Roosevelt Hospital" are "HIV Infections" (18 trials), "Breast Cancer" (7 trials), "Lung Cancer" (7 trials), "Obesity" (6 trials) and "Heart Failure" (5 trials). Many other conditions were trialed in "St. Lukes Roosevelt Hospital" in a lesser frequency.

Most popular intervention types in "St. Lukes Roosevelt Hospital" are "Drug" (70 trials), "Procedure" (19 trials), "Device" (17 trials), "Biological" (14 trials) and "Other" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "AC2993" (4 trials), "Lamivudine" (4 trials), "Nelfinavir mesylate" (4 trials) and "therapeutic conventional surgery" (4 trials). Other intervention names were less common.

The vast majority of trials in "St. Lukes Roosevelt Hospital" are 120 trials for "All" genders, 12 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "St. Lukes Roosevelt Hospital". 1 are not yet recruiting, 5 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 89 completed trials in St. Lukes Roosevelt Hospital, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in St. Lukes Roosevelt Hospital, 5 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 33 trials that are defined as “Not Applicable".